These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7580302)

  • 1. Synthetic recombinant vaccines against viral agents.
    Arnon A; Levi R
    Int Arch Allergy Immunol; 1995 Dec; 108(4):321-6. PubMed ID: 7580302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus.
    Donnelly JJ; Friedman A; Martinez D; Montgomery DL; Shiver JW; Motzel SL; Ulmer JB; Liu MA
    Nat Med; 1995 Jun; 1(6):583-7. PubMed ID: 7585127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection.
    Levi R; Arnon R
    Vaccine; 1996 Jan; 14(1):85-92. PubMed ID: 8821654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization against viral proteins with naked DNA.
    Ulmer JB; Donnelly JJ; Deck RR; DeWitt CM; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():117-25. PubMed ID: 8546384
    [No Abstract]   [Full Text] [Related]  

  • 5. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice.
    Ninomiya A; Ogasawara K; Kajino K; Takada A; Kida H
    Vaccine; 2002 Aug; 20(25-26):3123-9. PubMed ID: 12163263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization.
    Fu TM; Friedman A; Ulmer JB; Liu MA; Donnelly JJ
    J Virol; 1997 Apr; 71(4):2715-21. PubMed ID: 9060624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
    Powell TJ; Peng Y; Berthoud TK; Blais ME; Lillie PJ; Hill AV; Rowland-Jones SL; McMichael AJ; Gilbert SC; Dong T
    PLoS One; 2013; 8(5):e62778. PubMed ID: 23658773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model.
    Rota PA; De BK; Shaw MW; Black RA; Gamble WC; Kendal AP
    Virus Res; 1990 Apr; 16(1):83-93. PubMed ID: 2349834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to a Murray Valley encephalitis virus epitope expressed in the flagellin of an attenuated strain of Salmonella.
    Whittle BL; Lee E; Weir RC; Verma NK
    J Med Microbiol; 1997 Feb; 46(2):129-38. PubMed ID: 9060872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective properties of candidate genetically engineered vaccines against avian influenza viruses constructed on the basis of recombinant adenoviral vectors].
    Sedova ES; Shmarov MM; Tutykhina IL; Barykova IuA; Verkhovskaia LV; Logunov DIu; Naroditskiĭ BS; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (3):44-8. PubMed ID: 20734718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus.
    Jeon SH; Ben-Yedidia T; Arnon R
    Vaccine; 2002 Jun; 20(21-22):2772-80. PubMed ID: 12034104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of intramuscular immunization with naked DNA.
    Donnelly JJ; Ulmer JB; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():40-6. PubMed ID: 8546412
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral immunization with recombinant Lactococcus lactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responses.
    Wang Z; Gao J; Yu Q; Yang Q
    Future Microbiol; 2012 Aug; 7(8):1003-10. PubMed ID: 22913358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice.
    Tsuji M; Bergmann CC; Takita-Sonoda Y; Murata K; Rodrigues EG; Nussenzweig RS; Zavala F
    J Virol; 1998 Aug; 72(8):6907-10. PubMed ID: 9658144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
    Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L
    Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against homologous influenza challenge by genetic immunization with SFV-RNA encoding Flu-HA.
    Dalemans W; Delers A; Delmelle C; Denamur F; Meykens R; Thiriart C; Veenstra S; Francotte M; Bruck C; Cohen J
    Ann N Y Acad Sci; 1995 Nov; 772():255-6. PubMed ID: 8546401
    [No Abstract]   [Full Text] [Related]  

  • 19. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
    Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
    PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.